Six pharmacies, named, with their stock state
Twenty-six of the ninety-five sellers here name a pharmacy at all. Most of the rest describe a category — licensed, FDA-registered, 503A — and leave it there. Pomegranate publishes a list under each drug on its ordering screen, and the list is not decorative: one entry is marked sold out, which is live inventory rather than marketing.
It goes further than the list. Beside one dispenser sits a notice explaining that under a named regulation on compounded sterile preparations and beyond-use dating, that pharmacy may only dispense a single vial per order. That is a supply constraint quoted from the rule that causes it, published before checkout.
This is the disclosure most readers should want and almost never get. A named pharmacy is one you can look up in a state board register. A pharmacy with its stock state attached is one you can plan around.
The advertised figure is a floor under a matrix
The product page says the price starts at a figure. That word is doing work. On the ordering app the same drug appears above two controls — a plan length running from one month to six, and a tier labelled starter or advanced — and the page's text carries only the single number.
So the published figure describes one cell of a grid whose other cells are not published anywhere we could read. That is not a hidden fee; it is an unpublished plan. Our record stores the figure with the qualifier saying exactly that, rather than presenting it as a monthly rate.
The tirzepatide lane behaves the same way, and both products are sold as combination preparations — the semaglutide with a B vitamin, the tirzepatide with a form of B3. A combination preparation is not the same product as the plain drug, and anyone comparing these figures against a single-ingredient preparation elsewhere is comparing different things.
The brand-name product has no cash price
Three items on the ordering screen — an oral brand-name GLP-1, a combination weight medication and metformin — are each priced as a copay, described as being as low as nothing. That is not a cash rate. It presupposes a plan that is already paying, and this seller does not sell coverage.
Our record keeps that figure out of the price rows entirely and puts it in the field for coverage-conditioned figures instead. Four of the ninety-five rows here carry a figure that holds only once coverage is in place, and this is one of them. A zero printed as a cash price would be the single most misleading number on this site.
It is still worth knowing the lane exists. An FDA-approved oral GLP-1 sitting on the same screen as two compounded preparations tells you the operator can route a prescription either way. It just does not tell you what the approved one costs if you are paying yourself.
What it says about itself, and what it does not
The operating company is named in the first person in the HIPAA privacy policy, which is a real disclosure. No individual clinician is named anywhere on the pages we read. Fifty-one of the ninety-five sellers here name nobody who prescribes.
The absence of a membership fee is stated three separate ways on the priced page: the header strip says there are no membership requirements and no hidden fees, the card says there are no additional fees or membership costs, and the FAQ answers the insurance question by saying one clear price covers care, medication and shipping. Forty-one of the ninety-five sellers here charge no membership.
There is no state list. Fifty-eight of the ninety-five sellers here publish no service area at all, so the silence is ordinary. What is not ordinary is that the only geography on the site is a published surcharge for shipping to Alaska, Puerto Rico and Hawaii — which implies those destinations are served without ever saying which others are.
One line on the product page sits awkwardly beside the rest. It says the medication comes direct from an FDA-licensed manufacturer. Two paragraphs down the same page states, correctly, that compounded formulations are not reviewed or approved by the FDA. Both sentences are on one screen.
Pomegranate Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $119/mo"Compounded Semaglutide / Starts @ $119/mo" on the product page, and on the ordering app "Semaglutide / Semaglutide + Cyanocobalamin (B12) / $119/month". ⚠ The app screen carries plan-length controls (1, 2, 4 and 6 months) and Starter/Advanced tiers above a pharmacy picker; only the one figure is printed in text, so this is the floor of a matrix whose other cells are not published. | September 2026source |
| Tirzepatide (compounded) | $199/mo"Tirzepatide / Tirzepatide + Niacinamide (B3) / Dual-action medication that reduces appetite and promotes sustainable weight loss. / $199/month", under the same plan-length and tier controls. ⚠ A shipping surcharge is published beside it: "Alaska, PR & Hawaii Shipping: A $60 shipping surcharge applies." | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 95 providers reviewed here are paid partners today; the other 91 are not. See how this works.
See Pomegranate Health's current price →Good fit if
- Readers who want to know which pharmacy will fill the prescription — six are named, with stock state, before you pay.
- Buyers who want a supply constraint explained with the regulation behind it rather than discovered when an order is short.
- People who want the Alaska, Puerto Rico and Hawaii shipping surcharge published as a number rather than appearing at checkout.
- Anyone who wants a stated absence of membership fees rather than silence.
Look elsewhere if
- Anyone comparing on the headline. It is the floor of a plan-length and tier matrix whose other cells carry no published figure.
- Readers who want a self-pay price for the FDA-approved oral product. The only figure attached to it is a copay, and a copay is not a price.
- Buyers who want the prescribing clinician named. Nobody is named on any page we read.
- Anyone who needs their state confirmed. The only geography published is a shipping surcharge.
- Readers who want a single-ingredient preparation. Both compounded products here are sold as combinations with an added vitamin.
How this review was verified
- Re-read the homepage, the compounded semaglutide product page, the ordering app pricing screen and the HIPAA privacy policy on 6 September 2026 rather than carrying any figure across from the research file that nominated this seller.
- Fetched the marketing host and the ordering host separately, each with its own nonsense-path control in the same run. Both returned 404 to the control while the real pages returned 200, so a 200 from either host means something.
- Printed the status, byte size and effective URL of every fetch and compared the effective path to the requested one.
- Extracted the pharmacy list from a Python html.parser pass over text nodes only, with residual markup asserted absent, so the six names are rendered text rather than markup found in a payload.
- Recorded the brand-name copay in the coverage-conditioned field rather than as a price row, and checked that no page publishes a self-pay figure for that product.
- Read the plan-length and tier controls on the ordering screen and confirmed that only one figure per drug appears in the page's own text, which is why the stored figure is described as a floor rather than a rate.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a positive control and a nonsense-string negative control in the same run. The full-text hits returned were unrelated food-operations recipients; no letter to this company appeared. Untitled letters are published separately and were not searched.